C
ATRS

Covestor’s Antares Pharma, Inc. ATRS Stock Holding History

Covestor’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-644
Closed -$3K – 2547
2022
Q1 		$3K Buy
644
+352
+121% +$1.28K ﹤0.01% 1644
2021
Q4 		$1K Buy
+292
New +$1.02K ﹤0.01% 2060

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Covestor's ATRS Position: Q2 2022 in Review

Covestor sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 644 shares — an estimated $3K sold.

Covestor first reported a position in ATRS in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Covestor reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Covestor sold 644 Antares Pharma, Inc. shares in Q2 2022, an estimated $3K.
  • Covestor first reported a position in Antares Pharma, Inc. in Q4 2021 and held it in 2 quarters.
  • Covestor's Antares Pharma, Inc. position peaked at $3K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Covestor's 13F filing for Q2 2022, filed 10 Aug 2022.